TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Smerud Medical Research International AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
107,987
|
95,041
|
63,056 |
| Financial expenses |
1,472
|
2,105
|
2,837 |
| Earnings before taxes |
10,392
|
20,159
|
5,812 |
| Total assets |
47,612
|
40,166
|
47,467 |
| Current assets |
43,479
|
35,875
|
43,036 |
| Current liabilities |
21,161
|
22,306
|
34,649 |
| Equity capital |
26,451
|
17,860
|
12,818 |
| - share capital |
110
|
110
|
110 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
55.6%
|
44.5%
|
27.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
9.6%
|
21.2%
|
9.2% |
| Return on assets (ROA) |
24.9%
|
55.4%
|
18.2% |
| Current ratio |
205.5%
|
160.8%
|
124.2% |
| Return on equity (ROE) |
39.3%
|
112.9%
|
45.3% |
| Change turnover |
12,946
|
31,985
|
28,489 |
| Change turnover % |
14%
|
51%
|
82% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.